Comprehensive Introduction to Type and Crossmatch

In the realm of modern medicine, particularly within surgical, trauma, and hematological specialties, few diagnostic procedures are as critical to patient safety as the Type and Crossmatch. Often referred to simply as "T&C," this laboratory service is the gold standard for ensuring that a patient receives a blood transfusion that is immunologically compatible with their own system.

A Type and Crossmatch is a two-part process. The "Type" determines the patient’s ABO blood group and Rh factor, while the "Crossmatch" involves physically mixing the patient’s serum with the donor’s red blood cells to check for adverse reactions. This guide serves as an authoritative resource for clinicians, medical students, and healthcare professionals to understand the nuances of this life-saving protocol.

Technical Specifications and Mechanisms

The Type and Crossmatch process is governed by the principles of immunohematology. It relies on detecting antigens on the surface of red blood cells (RBCs) and the corresponding antibodies in the plasma.

The Two-Phase Process

1. Blood Typing (ABO/Rh): This identifies the presence of A and B antigens on the RBC surface and the presence or absence of the Rh(D) protein.
2. Crossmatching: This is the final safety check. It involves incubating the patient’s serum with the donor’s RBCs. If the patient has antibodies against the donor cells, agglutination (clumping) or hemolysis (destruction of cells) will occur.

Types of Crossmatches

Extensive Clinical Indications and Usage

The decision to order a Type and Crossmatch is based on the patient's risk of hemorrhage and their baseline hematological status.

Surgical Indications

• Elective Orthopedic Surgery: Total joint arthroplasty (hip/knee) often requires blood availability due to potential intraoperative blood loss.
• Trauma/Emergency Surgery: Patients presenting with hemodynamic instability or high-energy fractures.
• Cardiac/Vascular Procedures: Surgeries involving cardiopulmonary bypass or major vessel repair.

Hematological Indications

• Chronic Anemia: Patients requiring regular transfusions due to conditions like sickle cell disease or thalassemia.
• Oncology: Patients undergoing aggressive chemotherapy or radiation that may induce transient bone marrow suppression.
• Obstetrics: High-risk pregnancies (e.g., placenta previa) where the risk of postpartum hemorrhage is elevated.

Specimen Collection and Laboratory Protocol

The accuracy of a Type and Crossmatch is entirely dependent on the integrity of the specimen collection process. Errors in labeling are the most common cause of transfusion-related fatalities.

Collection Guidelines

• Identification: Two-person verification is required at the bedside.
• Tube Requirements: Generally a lavender-top (EDTA) tube or a pink-top (contains blood banking additive).
• Labeling: Must include patient name, medical record number, date, time, and the phlebotomist’s initials.
• Rejection Criteria: Unlabeled tubes, illegible handwriting, or mismatched labels with the requisition form will result in immediate rejection by the blood bank.

Interfering Factors and Considerations

Several factors can lead to false results or difficulty in finding compatible blood:

• Recent Transfusions: If a patient has been transfused in the last three months, circulating alloantibodies may be present.
• Medications: Certain drugs like methyldopa or high-dose penicillin can cause a positive Direct Antiglobulin Test (DAT), complicating the crossmatch.
• Autoimmune Diseases: Conditions like Systemic Lupus Erythematosus (SLE) can cause autoantibodies that react with all donor cells, making it difficult to find "compatible" blood (requiring specialized "least incompatible" protocols).
• Pregnancy: Exposure to fetal blood during pregnancy can result in the development of maternal antibodies.

Risks and Contraindications

While the Type and Crossmatch is a safety measure, the transfusion itself carries inherent risks.

• Hemolytic Transfusion Reactions: Occur when incompatible blood is administered. Symptoms include fever, flank pain, hypotension, and hemoglobinuria.
• Transfusion-Related Acute Lung Injury (TRALI): A severe reaction characterized by respiratory distress.
• Febrile Non-Hemolytic Reactions: Common and generally mild, usually managed with antipyretics.
• Fluid Overload (TACO): Transfusion-Associated Circulatory Overload, particularly in elderly patients with congestive heart failure.

Massive FAQ Section: Frequently Asked Questions

1. What is the difference between "Type and Screen" and "Type and Crossmatch"?

A "Type and Screen" identifies the blood type and checks for common antibodies but does not set aside specific units of blood. "Type and Crossmatch" physically selects and tests specific donor units against the patient’s serum for immediate availability.

2. How long is a Type and Crossmatch valid?

Due to the risk of developing new antibodies, a crossmatch is generally valid for 72 hours. After this period, a new sample is required.

3. Can I perform a Type and Crossmatch on a patient who has received an IV fluid bolus?

Yes, but avoid drawing the blood from the same limb where an IV infusion is running, as the dilutional effect can interfere with accurate lab results.

4. What happens if no compatible blood is found?

The hospital’s blood bank will consult with a pathologist. They may use specialized "phenotyped" blood or consult a national reference laboratory to find rare donor units.

5. Is there a way to bypass the 45-minute wait for a crossmatch?

In extreme emergencies, O-negative "universal donor" blood can be released before crossmatching is complete. This is a high-risk procedure reserved for life-threatening hemorrhage.

6. What is the "Rh factor" and why does it matter?

The Rh factor is a protein on red blood cells. If you have it, you are Rh-positive. If you don't, you are Rh-negative. Rh-negative patients should generally receive Rh-negative blood to prevent alloimmunization.

7. Does a Type and Crossmatch detect all viruses?

No. While blood centers perform rigorous testing for HIV, Hepatitis B/C, and Syphilis, the Type and Crossmatch is strictly for immunological compatibility, not infection screening.

8. What is an "Emergency Release" of blood?

This is when a physician signs a waiver to accept un-crossmatched blood to save a life, acknowledging the risk of a potential hemolytic reaction.

9. Can a patient have an allergic reaction even if the crossmatch is perfect?

Yes. Some patients are sensitive to plasma proteins in the donor blood, which can cause hives or anaphylaxis, regardless of blood type compatibility.

10. Why is the pink-top tube preferred in many institutions?

Pink-top tubes are specifically designed for blood banking with additives that preserve the integrity of red cell antigens and are often linked to automated labeling systems to reduce human error.

Conclusion

The Type and Crossmatch is a cornerstone of clinical safety. By understanding the immunological mechanisms behind ABO and Rh compatibility, as well as the strict protocols surrounding specimen collection, medical professionals can significantly reduce the incidence of transfusion-related complications. Always prioritize the "two-person" verification rule, maintain awareness of patient history (previous transfusions/pregnancies), and ensure that the blood bank is notified well in advance of any anticipated surgical blood needs. Through rigorous adherence to these standards, we ensure that blood transfusion remains a life-saving intervention rather than a source of preventable harm.